Horizontal gene transfer in a polyclonal outbreak of carbapenem-resistant Acinetobacter baumannii

Journal of Clinical Microbiology

Volumn 45, Issue 2, 2007, Pages 453-460

  Valenzuela, Jubelle K ^a   Thomas, Lee ^a,b   Partridge, Sally R ^a   Van Der Reijden, Tanny ^c   Dijkshoorn, Lenie ^c   Iredell, Jon ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC RESISTANCE GENE; ARTICLE; AUSTRALIA; BACTERIAL GENE; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIUM ISOLATE; BLAOXA 23 GENE; BLAOXA 51 LIKE GENE; DRUG HYDROLYSIS; EPIDEMIC; HORIZONTAL GENE TRANSFER; HUMAN; INTEGRON; INTENSIVE CARE UNIT; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; AUSTRALIA; BACTERIAL PROTEINS; CARBAPENEMS; DISEASE OUTBREAKS; DRUG RESISTANCE, BACTERIAL; GENE TRANSFER, HORIZONTAL; HUMANS; MOLECULAR SEQUENCE DATA; SEQUENCE ANALYSIS, DNA;

ACINETOBACTER; ACINETOBACTER BAUMANNII;

EID: 33847059972     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01971-06     Document Type: Article

References (56)

1. Abbott, Y., R. O'Mahony, N. Leonard, P. J. Quinn, T. van der Reijden, L. Dijkshoorn, and S. Fanning. 2005. Characterization of a 2.6 kbp variable region within a class 1 integron found in an Acinetobacter baumannii strain isolated from a horse. J. Antimicrob. Chemother. 55:367-370.
2. Afzal-Shah, M., N. Woodford, and D. M. Livermore. 2001. Characterization of OXA-25, OXA-26, and OXA-27, molecular class D β-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii. Antimicrob. Agents Chemother. 45:583-588.
3. Bergogne-Bérézin, E., and K. J. Towner. 1996. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin. Microbiol. Rev. 9:148-165.
4. Bou, G., A. Oliver, and J. Martínez-Beltrán. 2000. OXA-24, a novel class D β-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain. Antimicrob. Agents Chemother. 44:1556-1561.
5. Centrón, D., and P. H. Roy. 2002. Presence of a group II intron in a multiresistant Serratia marcescens strain that harbors three integrons and a novel gene fusion. Antimicrob. Agents Chemother. 46:1402-1409.
6. Dalla-Costa, L. M., J. M. Coelho, H. A. Souza, M. E. Castro, C. J. Stier, K. L. Bragagnolo, A. Rea-Neto, S. R. Penteado-Filho, D. M. Livermore, and N. Woodford. 2003. Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, Brazil. J. Clin. Microbiol. 41: 3403-3406.
7. De, A., and L. Deodhar. 1995. Antibiotic resistance pattern and R-plasmids of Acinetobacter calcoaceticus subsp. anitratus. Indian J. Pathol. Microbiol. 38:185-188.
8. Dehio, C., and M. Meyer. 1997. Maintenance of broad-host-range incompatibility group P and group Q plasmids and transposition of Tn5 in Bartonella henselae following conjugal plasmid transfer from Escherichia coli. J. Bacteriol. 179:538-540.
9. 8a. de la Cruz, and J. Grinsted. 1982. Genetic and molecular characterization of Tn21, a multiple resistance transposon from R100.1. J. Bacteriol. 151:222-228.
10. Dijkshoorn, L., B. Van Harsselaar, I. Tjernberg, P. J. Bouvet, and M. Vaneechoutte. 1998. Evaluation of amplified ribosomal DNA restriction analysis for identification of Acinetobacter genomic species. Syst. Appl. Microbiol. 21:33-39.
11. Dillon, B., L. Thomas, G. Mohmand, A. Zelynski, and J. Iredell. 2005. Multiplex PCR for screening of integrons in bacterial lysates. J. Microbiol. Methods 62:221-232.
12. Donald, H. M., W. Scaife, S. G. Amyes, and H.-K. Young. 2000. Sequence analysis of ARI-1, a novel OXA β-lactamase, responsible for imipenem resistance in Acinetobacter baumannii 6B92. Antimicrob. Agents Chemother. 44:196-199.
13. Fernández-Cuenca, F., L. Martínez-Martínez, M. C. Conejo, J. A. Ayala, E. J. Perea, and A. Pascual. 2003. Relationship between β-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii. J. Antimicrob. Chemother. 51:565-574.
14. Fournier, P. E., D. Vallenet, V. Barbe, S. Audic, H. Ogata, L. Poirel, H. Richet, C. Robert, S. Mangenot, C. Abergel, P. Nordmann, J. Weissenbach, D. Raoult, and J.-M. Claverie. 2006. Comparative genomics of multidrug resistance in Acinetobacter baumannii. PLoS Genet. 2:62-72.
15. Garcia, D. C., M. M. Nociari, D. O. Sordelli, A. Di Martino, and M. Catalano. 1996. The use of plasmid profile analysis and ribotyping for typing Acinetobacter baumannii isolates. J. Hosp. Infect. 34:139-144.
16. Gombac, F., M. L. Riccio, G. M. Rossolini, C. Lagatolla, E. Tonin, C. Monti-Bragadin, A. Lavenia, and L. Dolzani. 2002. Molecular characterization of integrons in epidemiologically unrelated clinical isolates of Acinetobacter baumannii from Italian hospitals reveals a limited diversity of gene cassette arrays. Antimicrob. Agents Chemother. 46:3665-3668.
17. Grundmann, H. J., K. J. Towner, L. Dijkshoorn, P. Gerner-Smidt, M. Maher, H. Seifert, and M. Vaneechoutte. 1997. Multicenter study using standardized protocols and reagents for evaluation of reproducibility of PCR-based fingerprinting of Acinetobacter spp. J. Clin. Microbiol. 35:3071-3077.
18. Héritier, C., A. Dubouix, L. Poirel, N. Marty, and P. Nordmann. 2005. A nosocomial outbreak of Acinetobacter baumannii isolates expressing the carbapenem-hydrolysing oxacillinase OXA-58. J. Antimicrob. Chemother. 55: 115-118.
19. Héritier, C., L. Poirel, T. Lambert, and P. Nordmann. 2005. Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumannii. Antimicrob. Agents Chemother. 49:3198-3202.
20. IMP-4) gene cassettes in class 1 integrons in Acinetobacter strains isolated from blood cultures in 1997 to 2000. Antimicrob. Agents Chemother. 47:1382-1390.
21. Jeon, B.-C., S. H. Jeong, I. K. Bae, S. B. Kwon, K. Lee, D. Young, J. H. Lee, J. S. Song, and S. H. Lee. 2005. Investigation of a nosocomial outbreak of imipenem-resistant Acinetobacter baumannii producing the OXA-23 β-lactamase in Korea. J. Clin. Microbiol. 43:2241-2245.
22. Kado, C. I., and S.-T. Liu. 1981. Rapid procedure for detection and isolation of large and small plasmids. J. Bacteriol. 145:1365-1373.
23. Koeleman, J. G., J. Stoof, M. W. Van Der Bijl, C. M. Vandenbroucke-Grauls, and P. H. Savelkoul. 2001. Identification of epidemic strains of Acinetobacter baumannii by integrase gene PCR. J. Clin. Microbiol. 39:8-13.
24. Lee, K., Y. Chong, H. B. Shin, Y. A. Kim, D. Yong, and J. H. Yum. 2001. Modified Hodge and EDTA-disk synergy tests to screen metallo-β- lactamase-producing strains of Pseudomonas and Acinetobacter species. Clin. Microbiol. Infect. 7:88-91.
25. Limansky, A. S., M. A. Mussi, and A. M. Viale. 2002. Loss of a 29-kilodalton outer membrane protein in Acinetobacter baumannii is associated with imipenem resistance. J. Clin. Microbiol. 40:4776-4778.
26. Masuda, G., S. Tomioka, and M. Hasegawa. 1976. Detection of β-lactamase production by gram-negative bacteria. J Antibiot. (Tokyo) 29:662-664.
27. Mazel, D., B. Dychinco, V. A. Webb, and J. Davies. 2000. Antibiotic resistance in the ECOR collection: integrons and identification of a novel aad gene. Antimicrob. Agents Chemother. 44:1568-1574.
28. Naas, T., M. Levy, C. Hirschauer, H. Marchandin, and P. Nordmann. 2005. Outbreak of carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-23 in a tertiary care hospital of Papeete, French Polynesia. J. Clin. Microbiol. 43:4826-4829.
29. Nemec, A., L. Dijkshoorn, and P. Jezek. 2000. Recognition of two novel phenons of the genus Acinetobacter among non-glucose-acidifying isolates from human specimens. J. Clin. Microbiol. 38:3937-3941.
30. Nemec, A., L. Dijkshoorn, and T. J. van der Reijden. 2004. Long-term predominance of two pan-European clones among multi-resistant Acinetobacter baumannii strains in the Czech Republic. J. Med. Microbiol. 53:147- 153.
31. Nemec, A., L. Dolzani, S. Brisse, P. van den Broek, and L. Dijkshoorn. 2004. Diversity of aminoglycoside-resistance genes and their association with class 1 integrons among strains of pan-European Acinetobacter baumannii clones. J. Med. Microbiol. 53:1233-1240.
32. Osborne, R. S., and T. J. Silhavy. 1993. PrlA suppressor mutations cluster in regions corresponding to three distinct topological domains. EMBO J. 12: 3391-3398.
33. Partridge, S. R., H. J. Brown, and R. M. Hall. 2002. Characterization and movement of the class 1 integron known as Tn2521 and Tn1405. Antimicrob. Agents Chemother. 46:1288-1294.
34. Playford, E. G., J. C. Craig, and J. R. Iredell. Carbapenem-resistant Acinetobacter baumanii in intensive care unit patients: risk factors for acquisition, infection and their consequences. J. Hosp. Infect., in press.
35. Poirel, L., and P. Nordmann. 2006. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin. Microbiol. Infect. 12:826-836.
36. OXA-58 in Acinetobacter baumannii. Antimicrob. Agents Chemother. 50: 1442-1448.
37. OXA-23 in Acinetobacter baumannii, abstr. C1-57. Abstr. 46th Intersci. Conf. Antimicrob. Agents Chemother.
38. Ribera, A., J. Vila, F. Fernández-Cuenca, L. Martínez-Martínez, A. Pascual, A. Beceiro, G. Bou, J. M. Cisneros, J. Pachón, and J. Rodríguez-Bano. 2004. Type 1 integrons in epidemiologically unrelated Acinetobacter baumannii isolates collected at Spanish hospitals. Antimicrob. Agents Chemother. 48: 364-365.
39. Sambrook, J., and D. W. Russell. 2001. Molecular cloning: a laboratory manual, 3rd ed., vol. 1. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
40. 37a. Scaife, W., H.-K. Young, R. H. Paton, and S. G. B. Amyes. 1995. Letter. J. Antimicrob. Chemother. 36:585-587.
41. ABA-1 customized for Acinetobacter? FEMS Microbiol. Lett. 243:425-429.
42. Segal, H., E. C. Nelson, and B. G. Elisha. 2004. Genetic environment and transcription of ampC in an Acinetobacter baumannii clinical isolate. Antimicrob. Agents Chemother. 48:612-614.
43. Segal, H., R. Thomas, and B. G. Elisha. 2003. Characterization of class 1 integron resistance gene cassettes and the identification of a novel IS-like element in Acinetobacter baumannii. Plasmid 49:169-178.
44. Seifert, H., L. Dolzani, R. Bressan, T. van der Reijden, B. van Strijen, D. Stefanik, H. Heersma, and L. Dijkshoorn. 2005. Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresis-generated fingerprints of Acinetobacter baumannii. J. Clin. Microbiol. 43: 4328-4335.
45. TMP in gram-negative rods resistant to broad-spectrum β-lactams. J. Clin. Microbiol. 34:2909-2913.
46. Shahcheraghi, F., M. M. Feizabadi, V. Yamin, R. Abiri, and Z. Abedian. 2003. Serovar determination, drug resistance patterns and plasmid profiles of Pseudomonas aeruginosa isolated from burn patients at two hospitals of Tehran (Iran). Burns 29:547-551.
47. Shibata, N., Y. Doi, K. Yamane, T. Yagi, H. Kurokawa, K. Shibayama, H. Kato, K. Kai, and Y. Arakawa. 2003. PCR typing of genetic determinants for metallo-β-lactamases and integrases carried by gram-negative bacteria isolated in Japan, with focus on the class 3 integron. J. Clin. Microbiol. 41: 5407-5413.
48. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
49. Tsakris, A., S. Pournaras, N. Woodford, M. F. Palepou, G. S. Babini, J. Douboyas, and D. M. Livermore. 2000. Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece. J. Clin. Microbiol. 38:1290-1292.
50. Turton, J. F., M. E. Kaufmann, J. Glover, J. M. Coelho, M. Warner, R, Pike, and T. L. Pitt. 2005. Detection and typing of integrons in epidemic strains of Acinetobacter baumannii found in the United Kingdom. J. Clin. Microbiol. 43:3074-3082.
51. Turton, J. F., M. E. Ward, N. Woodford, M. E. Kaufmann, R. Pike, D. M. Livermore, and T. L. Pitt. 2006. The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol. Lett. 258:72-77.
52. Walsh, T. R., M. A. Toleman, L. Poirel, and P. Nordmann. 2005. Metallo-β-lactamases: the quiet before the storm? Clin. Microbiol. Rev. 18:306-325.
53. White, P. A., C. J. McIver, Y.-M. Deng, and W. D. Rawlinson. 2000. Characterisation of two new gene cassettes, aadA5 and dfrA17. FEMS Microbiol. Lett. 182:265-269.
54. Wroblewska, M. M., L. Dijkshoorn, H. Marchel, M. van den Barselaar, E. Swoboda-Kopec, P. J. van den Broek, and M. Luczak. 2004. Outbreak of nosocomial meningitis caused by Acinetobacter baumannii in neurosurgical patients. J. Hosp. Infect. 57:300-307.
55. Yu, Y. S., Q. Yang, X. W. Xu, H. S. Kong, G. Y. Xu, and B. Y. Zhong. 2004. Typing and characterization of carbapenem-resistant Acinetobacter calcoaceticus-baumannii complex in a Chinese hospital. J. Med. Microbiol. 53:653-656.
56. Zarrilli, R., M. Crispino, M. Bagattini, E. Barretta, A. Di Popolo, M. Triassi, and P. Villari. 2004. Molecular epidemiology of sequential outbreaks of Acinetobacter baumannii in an intensive care unit shows the emergence of carbapenem resistance. J. Clin. Micvobiol. 42:946-953.